Form 4 · Filed Jul 17, 2026, 08:15 PM UTC
CPRX/CATALYST PHARMACEUTICALS, INC.
Miller Steve — Chief Op. & Scientific Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
11 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | D | other | 1,093,803 | $32 | $34,454,795 | 0 |
| Jul 15, 2026 | D | other | 180,000 | — | — | 0 |
| Jul 15, 2026 | D | other | 275,000 | — | — | 0 |
| Jul 15, 2026 | D | other | 185,000 | — | — | 0 |
| Jul 15, 2026 | D | other | 146,000 | — | — | 0 |
| Jul 15, 2026 | D | other | 248,004 | — | — | 0 |
| Jul 15, 2026 | D | other | 202,958 | — | — | 0 |
| Jul 15, 2026 | D | other | 158,454 | — | — | 0 |
| Jul 15, 2026 | D | other | 11,873 | — | — | 0 |
| Jul 15, 2026 | D | other | 16,534 | — | — | 0 |
| Jul 15, 2026 | D | other | 47,826 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001161697-26-000180